V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260007093 | 260005027 | 1.78 | 83.8 | Disease modification (D) | 2018-01-03 | 2018-01-08 | Bendamustine+Rituximab (1st Course) | 2 | N | 260025188 | BENDAMUSTINE + RITUXIMAB |
| 260007094 | 260005028 | null | 73.2 | Palliative (P) | 2017-06-12 | 2017-06-24 | BENDAMUSTINE + RITUXIMAB | N | N | 260025190 | BENDAMUSTINE + RITUXIMAB |
| 260007095 | 260005028 | null | 87 | Curative (C) | 2013-05-19 | 2013-05-20 | BENDAMUSTINE + RITUXIMAB | N | N | 260025190 | BENDAMUSTINE + RITUXIMAB |
| 260007096 | 260005028 | 1.56 | 64.2 | Palliative (P) | 2016-05-06 | 2016-05-18 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025190 | BENDAMUSTINE + RITUXIMAB |
| 260007097 | 260005029 | 1.68 | 63.9 | Palliative (P) | 2015-04-19 | 2015-04-19 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260025194 | BENDAMUSTINE + RITUXIMAB |
| 260007098 | 260005029 | 1.78 | 81 | Curative (C) | null | 2018-08-10 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025194 | BENDAMUSTINE + RITUXIMAB |
| 260007099 | 260005030 | 1.71 | 109.2 | Palliative (P) | 2013-08-14 | 2013-08-22 | BENDAMUSTINE + RITUXIMAB | N | N | 260025198 | BENDAMUSTINE + RITUXIMAB |
| 260007100 | 260011487 | 1.66 | 63 | Curative (C) | 2017-04-01 | 2017-04-04 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025200 | BENDAMUSTINE + RITUXIMAB |
| 260007101 | 260005031 | 1.73 | 89.2 | Not known (9) | 2017-03-26 | 2017-03-26 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025202 | BENDAMUSTINE + RITUXIMAB |
| 260007102 | 260011488 | 1.75 | 77.1 | Palliative (P) | 2013-04-13 | 2013-04-18 | BENDAMUSTINE + RITUXIMAB | N | N | 260025203 | BENDAMUSTINE + RITUXIMAB |
| 260007103 | 260005032 | 1.73 | null | Palliative (P) | null | 2019-02-07 | BENDAMUSTINE + RITUXIMAB | 99 | N | 260025204 | BENDAMUSTINE + RITUXIMAB |
| 260007104 | 260005033 | 1.65 | 52.4 | Disease modification (D) | 2015-09-22 | 2015-09-29 | BENDAMUSTINE + RITUXIMAB | N | N | 260025205 | BENDAMUSTINE + RITUXIMAB |
| 260007105 | 260011489 | 1.5 | 71.5 | Palliative (P) | 2018-01-17 | 2018-01-29 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260025211 | BENDAMUSTINE + RITUXIMAB |
| 260007106 | 260005034 | 1.54 | 68 | Curative (C) | 2014-08-05 | 2014-08-08 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025212 | BENDAMUSTINE + RITUXIMAB |
| 260007107 | 260011490 | 1.78 | 94 | Disease modification (D) | 2017-09-29 | 2017-10-09 | BENDAMUSTINE + RITUXIMAB | N | N | 260025213 | BENDAMUSTINE + RITUXIMAB |
| 260007108 | 260005035 | 1.56 | 93.8 | Palliative (P) | 2013-08-09 | 2013-08-10 | Bendamustine+Rituximab (1st Course) | N | N | 260025214 | BENDAMUSTINE + RITUXIMAB |
| 260007109 | 260005035 | 1.76 | 99.8 | Disease modification (D) | 2014-03-04 | 2014-03-12 | BENDAMUSTINE + RITUXIMAB | N | Y | 260025214 | BENDAMUSTINE + RITUXIMAB |
| 260007110 | 260005036 | 1.77 | 89 | Palliative (P) | 2018-07-02 | 2018-07-08 | BENDAMUSTINE + RITUXIMAB | N | N | 260025218 | BENDAMUSTINE + RITUXIMAB |
| 260007111 | 260005036 | 1.83 | 84.4 | Disease modification (D) | 2016-09-30 | 2016-10-09 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025218 | BENDAMUSTINE + RITUXIMAB |
| 260007112 | 260005037 | 1.85 | 77.2 | Disease modification (D) | 2015-08-10 | 2015-08-12 | Bendamustine+Rituximab (1st Course) | 02 | N | 260025221 | BENDAMUSTINE + RITUXIMAB |
| 260007113 | 260005038 | 1.92 | 64 | Disease modification (D) | 2013-05-27 | 2013-05-29 | BENDAMUSTINE + RITUXIMAB | N | N | 260025223 | BENDAMUSTINE + RITUXIMAB |
| 260007114 | 260005039 | 1.57 | 76 | Palliative (P) | 2016-11-15 | 2016-11-15 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025226 | BENDAMUSTINE + RITUXIMAB |
| 260007115 | 260005040 | 1.62 | 76 | Neo-adjuvant (N) | 2018-03-09 | 2018-03-11 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025228 | BENDAMUSTINE + RITUXIMAB |
| 260007116 | 260005041 | 1.73 | 68.4 | Curative (C) | 2013-10-04 | 2013-10-04 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025229 | BENDAMUSTINE + RITUXIMAB |
| 260007117 | 260005041 | 1.81 | 84 | Palliative (P) | 2014-12-31 | 2015-01-21 | Bendamustine+Rituximab (1st Course) | N | N | 260025229 | BENDAMUSTINE + RITUXIMAB |
| 260007118 | 260005042 | 1.64 | 70.1 | Palliative (P) | null | 2016-11-24 | Bendamustine+Rituximab (1st Course) | 2 | N | 260025232 | BENDAMUSTINE + RITUXIMAB |
| 260007119 | 260005043 | null | null | null | 2016-09-15 | 2016-09-15 | BENDAMUSTINE + RITUXIMAB | N | null | 260025233 | BENDAMUSTINE + RITUXIMAB |
| 260007120 | 260005044 | 1.79 | 80.4 | Disease modification (D) | 2016-04-26 | 2016-05-06 | BENDAMUSTINE + RITUXIMAB | N | null | 260025234 | BENDAMUSTINE + RITUXIMAB |
| 260007121 | 260005044 | 1.66 | 103 | Disease modification (D) | 2016-08-30 | 2016-09-19 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260025234 | BENDAMUSTINE + RITUXIMAB |
| 260007122 | 260005045 | 1.71 | 92.15 | Disease modification (D) | 2015-08-09 | 2015-08-16 | BENDAMUSTINE + RITUXIMAB | N | null | 260025236 | BENDAMUSTINE + RITUXIMAB |
| 260007123 | 260005046 | 1.64 | 56 | Palliative (P) | 2014-10-24 | 2014-10-24 | BENDAMUSTINE + RITUXIMAB | N | N | 260025238 | BENDAMUSTINE + RITUXIMAB |
| 260007124 | 260005046 | 1.67 | 95 | Palliative (P) | 2017-01-05 | 2017-01-28 | BENDAMUSTINE + RITUXIMAB | N | N | 260025238 | BENDAMUSTINE + RITUXIMAB |
| 260007125 | 260005047 | 1.72 | 80 | Disease modification (D) | 2016-09-20 | 2016-09-27 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260025240 | BENDAMUSTINE + RITUXIMAB |
| 260007126 | 260005047 | 1.72 | 73.4 | Palliative (P) | 2014-03-03 | 2014-03-03 | Bendamustine+Rituximab (1st Course) | N | N | 260025240 | BENDAMUSTINE + RITUXIMAB |
| 260007127 | 260005048 | 1.71 | 67.3 | Disease modification (D) | null | 2017-03-16 | BENDAMUSTINE + RITUXIMAB | N | N | 260025246 | BENDAMUSTINE + RITUXIMAB |
| 260007128 | 260011497 | 1.73 | 120.7 | Disease modification (D) | 2017-09-11 | 2017-10-06 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025247 | BENDAMUSTINE + RITUXIMAB |
| 260007129 | 260011497 | 1.72 | null | Palliative (P) | 2017-08-05 | 2017-08-05 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025247 | BENDAMUSTINE + RITUXIMAB |
| 260007130 | 260005049 | 1.75 | 84 | Curative (C) | 2015-11-06 | 2015-11-07 | BENDAMUSTINE + RITUXIMAB | N | N | 260025250 | BENDAMUSTINE + RITUXIMAB |
| 260007131 | 260011498 | 1.65 | 59.5 | Curative (C) | 2016-01-14 | 2016-01-19 | Bendamustine+Rituximab(Sub Courses) | 2 | N | 260025251 | BENDAMUSTINE + RITUXIMAB |
| 260007132 | 260005050 | 1.55 | 69 | Palliative (P) | 2015-05-03 | 2015-05-05 | CVP R | N | N | 260025256 | CVP R |
| 260007133 | 260011499 | 1.6 | 50.2 | Disease modification (D) | 2015-03-05 | 2015-03-17 | CVP R | N | null | 260025257 | CVP R |
| 260007134 | 260005051 | 1.75 | 86.1 | Curative (C) | 2017-01-29 | 2017-01-30 | CVP R | N | N | 260025259 | CVP R |
| 260007135 | 260005051 | 1.58 | 70.3 | Disease modification (D) | 2017-02-19 | 2017-02-20 | CVP R | 02 | N | 260025259 | CVP R |
| 260007136 | 260005052 | 1.58 | 76.6 | Not known (9) | 2016-08-29 | 2016-09-11 | CVP R | N | N | 260025263 | CVP R |
| 260007137 | 260005053 | 1.8 | 70.6 | Palliative (P) | 2015-07-27 | 2015-07-28 | CVP R | 02 | N | 260025265 | CVP R |
| 260007138 | 260005053 | 1.81 | 63.4 | Curative (C) | 2015-08-26 | 2015-08-26 | CVP R | 2 | N | 260025265 | CVP R |
| 260007139 | 260005054 | 1.7 | 81 | Disease modification (D) | 2013-06-19 | 2013-07-02 | CVP R | 02 | N | 260025268 | CVP R |
| 260007140 | 260005054 | 1.78 | 92 | null | 2014-06-21 | 2014-06-24 | CVP R | null | N | 260025268 | CVP R |
| 260007141 | 260005055 | 1.86 | 95.4 | Disease modification (D) | 2016-07-31 | 2016-07-31 | CVP R | 02 | N | 260025271 | CVP R |
| 260007142 | 260005055 | 1.7 | 79.2 | Palliative (P) | 2016-11-22 | 2016-12-02 | CVP R | N | N | 260025271 | CVP R |